Pharmaceutical Nanotechnology
SJR0.375
AE
AEJournal metrics
Annual Clarivate and SCImago indicators.
| Year | JCR | SJR | ||||
|---|---|---|---|---|---|---|
| IF | IF quartile | Rank (percentile) | SJR | SJR quartile | Rank (percentile) | |
| 2025 | — | — | 0.375 | Q3 | 51.0% | |
| 2024 | — | — | 0.326 | Q3 | 48.3% | |
| 2023 | — | — | 0.371 | Q2 | 55.3% | |
| 2022 | — | — | 0.371 | Q2 | 57.1% | |
| 2021 | — | — | 0.519 | Q2 | 68.3% | |
| 2020 | — | — | 0.486 | Q2 | 65.4% | |
| 2019 | — | — | 0.239 | Q2 | 45.1% | |
| 2018 | — | — | 0.135 | Q3 | 16.7% | |
Impact history
Annual SJR and Impact Factor trend.
SJR
Journal record
eISSN
2211-7393
ISSN
2211-7385
country
AEcoverage
2014-2026